Showing results (1951-1960 of 3,796) with videos related to

Sort By:
Pageof 380
Oncoimmunology|September 25, 2025
IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapyAna L Portillo, Misaal Mehboob, Genesis Snyder, et al.
Oncoimmunology|September 25, 2025
NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumabDavid Giraldos, Evelyn Galano-Frutos, Laura Cambronero-Arregui, et al.
Oncoimmunology|October 1, 2025
Selective serotonin reuptake inhibitors enhance cancer immunosurveillance by pleiotropic mechanismsKarla Alvarez-Valadez, Guido Kroemer, Mojgan Djavaheri-Mergny
Oncoimmunology|September 25, 2025
Natural killer cells in adoptive cell therapy: current landscape of genetic engineering strategiesMaría Burón, Anne Etxebarria, Maite Álvarez, et al.
Oncoimmunology|December 21, 2020
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanomaRicardo A de Azevedo, Einav Shoshan, Shanzhi Whang, et al.
Oncoimmunology|December 12, 2022
BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood αβ CD8+ T cellsHannes Forkel, Piotr Grabarczyk, Maren Depke, et al.
Oncoimmunology|April 2, 2020
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapyMaria Georganaki, Mohanraj Ramachandran, Sander Tuit, et al.
Oncoimmunology|September 14, 2020
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptideAdam C Mirando, Akash Patil, Christine I Rafie, et al.
Oncoimmunology|September 14, 2020
Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapseConcetta Elisa Onesti, Claire Josse, Delphine Boulet, et al.
Oncoimmunology|September 14, 2020
A novel gene signature to predict immune infiltration and outcome in patients with prostate cancerNing Shao, Hong Tang, Yuanyuan Mi, et al.
Pageof 380